NCT00991887

Brief Summary

The investigators hypothesized that radiation therapy could be safely administered acutely after elbow trauma, and it would decrease the number of patients that would require surgical excision of heterotopic ossification.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2005

Longer than P75 for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2009

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
7.2 years until next milestone

Results Posted

Study results publicly available

September 21, 2017

Completed
Last Updated

April 21, 2022

Status Verified

September 1, 2017

Enrollment Period

3.9 years

First QC Date

October 7, 2009

Results QC Date

April 18, 2011

Last Update Submit

April 19, 2022

Conditions

Keywords

Heterotopic OssificationDistal humerus Fracture-dislocations of the elbowRadiation Therapy

Outcome Measures

Primary Outcomes (1)

  • Mayo Elbow Performance Score

    Mayo Elbow Performance Score (MEPS) is an outcome tool based on a 100 point scale, with higher score indicating better function. It measures pain, stability, function, and motion. The score is graded on the basis of the MEPS as excellent (\>=90), good (75-89), fair (60-74), and poor (\<60).

    6 month

Study Arms (2)

No Radiation Therapy (XRT)

NO INTERVENTION

This group will not receive radiation therapy after surgery.

Radiation Therapy (XRT)

ACTIVE COMPARATOR

Radiotherapy will be administered no later than 72 hours postoperatively.

Radiation: Radiation Therapy (XRT)

Interventions

The dose will be 700 gray (derived unit of ionizing radiation dose in the International System of Units) in a single fraction, using AP-PA fields calculated to midplane. No Less than 6 MV energy photons will be used, and no bolus is placed on the skin. The field covers the entire joint, the antecubital fossa and the olecranon process. A strip of skin at the antecubital area is generally shielded, but is not an absolute requirement for this study.

Also known as: Treatment group
Radiation Therapy (XRT)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Skeletally mature patients with minimum age of 18 years and maximum age of 65.
  • Patients deemed appropriate for operative intervention by the treating physician.
  • Distal humerus intra-articular fractures (types 13-C1, C2, and C3), with or without proximal radius/ulna fractures - open or closed.
  • Fracture-dislocations of the elbow (ulno-humeral dislocation associated with proximal ulna and/or radius fractures) - open or closed.

You may not qualify if:

  • Head injury, quantified by Glasgow Coma Score (GCS) \< 13 at time of consent for operative intervention.
  • Burns \> 20% Total Body Area (TBA) or involving the operative site.
  • Patients with spinal cord injury affecting the upper extremities will be excluded.
  • Open fractures which cannot be closed primarily within 72 hours of initial operative intervention.
  • Patients with estimated life expectancy of less than one year due to preexisting condition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Elbow FracturesOssification, Heterotopic

Interventions

Radiotherapy

Condition Hierarchy (Ancestors)

Elbow InjuriesArm InjuriesWounds and InjuriesFractures, BonePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Results Point of Contact

Title
Rachel Seymour, PhD
Organization
Carolinas Medical Center

Study Officials

  • Michael J Bosse, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2009

First Posted

October 8, 2009

Study Start

September 1, 2005

Primary Completion

August 1, 2009

Study Completion

July 1, 2010

Last Updated

April 21, 2022

Results First Posted

September 21, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share